Attached files
| file | filename |
|---|---|
| EX-32.2 - HARROW HEALTH, INC. | ex32-2.htm |
| EX-32.1 - HARROW HEALTH, INC. | ex32-1.htm |
| EX-31.2 - HARROW HEALTH, INC. | ex31-2.htm |
| EX-31.1 - HARROW HEALTH, INC. | ex31-1.htm |
| EX-21.1 - HARROW HEALTH, INC. | ex21-1.htm |
| EX-10.55 - HARROW HEALTH, INC. | ex10-55.htm |
| EX-10.54 - HARROW HEALTH, INC. | ex10-54.htm |
| EX-10.53 - HARROW HEALTH, INC. | ex10-53.htm |
| 10-K - HARROW HEALTH, INC. | form10-k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-159159, 333-183488, 333-198674 and 333-220186 on Form S-8 and Registration Statement No. 333-198675, 333-215672 and 333-218308 on Form S-3 of our report dated March 8, 2018, relating to the consolidated financial statements of Imprimis Pharmaceuticals, Inc. and subsidiaries, appearing in this Annual Report on Form 10-K of Imprimis Pharmaceuticals, Inc. for the year ended December 31, 2017.
/s/ KMJ Corbin & Company LLP
Costa Mesa, California
March 8, 2018